{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:31:32Z","timestamp":1768685492733,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a fatal complication in the general population. However, there are few reports on CAPA in patients undergoing hemodialysis (HD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective observational cohort study was conducted at a single center between December 2020 and June 2021. We enrolled 21 HD patients with COVID-19 undergoing treatment and divided them into two groups, CAPA and non-CAPA (COVID-19 with and without pulmonary aspergillosis), and evaluated their characteristics, clinical outcomes and comorbidities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The log-rank test revealed that the 90-day survival rate after the initiation of treatment for COVID-19 was significantly lower in the CAPA (n\u00a0=\u00a06) than in the non-CAPA group (n\u00a0=\u00a015) (P\u00a0=\u00a00.0002), and the 90-day mortality rates were 66.6% and 0% in the CAPA and non-CAPA groups, respectively. In the CAPA group, four patients died due to respiratory failure (on Days 6 and 20), gastrointestinal bleeding (Day 8) and sepsis (Day 33); the reverse transcription-polymerase chain reaction (RT-PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remained positive when they died. The remaining two patients survived and the negative conversion of RT-PCR for SARS-CoV-2 was confirmed on Days 10 and 15. The negative conversion of serum (1, 3)-\u03b2-d-glucan (BDG) was confirmed on Day 15 in one patient; the BDG remained positive on Day 64 in the other.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CAPA is a fatal complication in HD patients and the general population. Therefore, clinicians should consider the possibility of testing for CAPA in patients undergoing HD. Mycological workups may be helpful for the early detection of CAPA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfac027","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T12:15:29Z","timestamp":1643285729000},"page":"985-991","source":"Crossref","is-referenced-by-count":6,"title":["COVID-19-associated pulmonary aspergillosis in hemodialysis patients"],"prefix":"10.1093","volume":"15","author":[{"given":"Mai","family":"Yamaoka","sequence":"first","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"},{"name":"Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-460X","authenticated-orcid":false,"given":"Masataka","family":"Banshodani","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Muraoka","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Kimura","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tani","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadanori","family":"Shintaku","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Moriishi","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kawanishi","sequence":"additional","affiliation":[{"name":"Kidney Disease and Blood Purification Therapy, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"2022042902142266600_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2022042902142266600_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","article-title":"Incidence and outcomes of COVID-19 in people with CKD: a systematic review and Meta-analysis","volume":"78","author":"Chung","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2022042902142266600_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/ndt\/gfaa261","article-title":"COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration","volume":"35","author":"Hilbrands","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2022042902142266600_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review","volume":"113","author":"Chong","year":"2021","journal-title":"J Hosp Infect"},{"key":"2022042902142266600_bib5","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3390\/jcm10112469","article-title":"Aspergillus in critically ill COVID-19 patients: a scoping review","volume":"10","author":"Yusuf","year":"2021","journal-title":"J Clin Med"},{"key":"2022042902142266600_bib6","first-page":"899","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","volume":"71","author":"Bartoletti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022042902142266600_bib7","doi-asserted-by":"crossref","first-page":"753659","DOI":"10.3389\/fmed.2021.753659","article-title":"Risk factors for invasive aspergillosis in patients admitted to the intensive care unit with Coronavirus disease 2019: a multicenter retrospective study","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2022042902142266600_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-associated pulmonary aspergillosis, March\u2013August 2020","volume":"27","author":"Salmanton-Garcia","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022042902142266600_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/jof7090720","article-title":"Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients","volume":"7","author":"Roudbary","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022042902142266600_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med"},{"key":"2022042902142266600_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/myc.13328","article-title":"Mortality in critically ill patients with Coronavirus disease 2019-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"},{"key":"2022042902142266600_bib12","first-page":"00474","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill Coronavirus disease 2019 patients\u2014a multinational observational study by the European Confederation of Medical Mycology","volume":"S1198-743X","author":"Prattes","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022042902142266600_bib13","doi-asserted-by":"crossref","first-page":"790.e1","DOI":"10.1016\/j.cmi.2020.12.005","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort","volume":"27","author":"Delliere","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2022042902142266600_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2022042902142266600_bib15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022042902142266600_bib16","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc5780","article-title":"Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review","volume":"11","author":"Cruz","year":"2007","journal-title":"Crit Care"},{"key":"2022042902142266600_bib17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients","volume":"166","author":"Sessler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2022042902142266600_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/kisup.2015.5","article-title":"Japanese society for dialysis therapy renal data registry\u2014a window through which we can view the details of Japanese dialysis population","volume":"5","author":"Hanafusa","year":"2015","journal-title":"Kidney Int Suppl (2011)"},{"key":"2022042902142266600_bib19","doi-asserted-by":"crossref","first-page":"00402","DOI":"10.1183\/23120541.00402-2021","article-title":"COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society","volume":"7","author":"Takazono","year":"2021","journal-title":"ERJ Open Res"},{"key":"2022042902142266600_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.kint.2020.09.006","article-title":"Results from the ERA-EDTA registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe","volume":"98","author":"Jager","year":"2020","journal-title":"Kidney Int"},{"key":"2022042902142266600_bib21","doi-asserted-by":"crossref","first-page":"e0244","DOI":"10.1097\/CCE.0000000000000244","article-title":"Risk factors for invasive pulmonary aspergillosis in critically ill patients with Coronavirus disease 2019-induced acute respiratory distress syndrome","volume":"2","author":"Chauvet","year":"2020","journal-title":"Crit Care Explor"},{"key":"2022042902142266600_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention","volume":"30","author":"Fardet","year":"2007","journal-title":"Drug Saf"},{"key":"2022042902142266600_bib23","doi-asserted-by":"crossref","first-page":"e0252057","DOI":"10.1371\/journal.pone.0252057","article-title":"Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia","volume":"16","author":"Pinzon","year":"2021","journal-title":"PLoS One"},{"key":"2022042902142266600_bib24","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2022042902142266600_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"key":"2022042902142266600_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6904-6-6","article-title":"Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy","volume":"6","author":"von Mach","year":"2006","journal-title":"BMC Clin Pharmacol"},{"key":"2022042902142266600_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","article-title":"Pharmacokinetic\/Pharmacodynamic profile of voriconazole","volume":"45","author":"Theuretzbacher","year":"2006","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac027\/42927033\/sfac027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/5\/985\/43462413\/sfac027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/5\/985\/43462413\/sfac027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:15:54Z","timestamp":1651198554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/15\/5\/985\/6517328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,1,29]]},"published-print":{"date-parts":[[2022,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac027","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,1,29]]}}}